PLX Operating Cash Flow (Statement)
Protalix Biotherapeutics Inc · Operating Cash Flow (Statement)
PLX Operating Cash Flow (Statement)
Latest reported$9.92Mperiod ending
PLX TTM Cash from Operations (-$610.00K → $9.92M)
TTM operating cash flow (statement)
High-resolution chart · PNG
PLX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 657,670 | |
| -55,587 | |
| -53,108 | |
| -278,642 | |
| -625,409 | |
| -980,063 | |
| -1,408,137 | |
| -1,698,222 | |
| -2,163,882 | |
| -1,341,280 | |
| -910,000 | |
| -700,000 | |
| -90,000 | |
| -610,000 | |
| -610,000 | |
| -450,000 | |
| -270,000 |